Go Pro

Oramed Pharmaceuticals (ORMP) Earnings Date, Estimates & Call Transcripts

Oramed Pharmaceuticals logo
$4.82 +0.01 (+0.21%)
Closing price 08/24/2026 04:00 PM Eastern
Extended Trading
$4.85 +0.03 (+0.62%)
As of 08/24/2026 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Oramed Pharmaceuticals Earnings Summary

Oramed Pharmaceuticals issued Q2 2026 earnings on August 10, 2026, reporting an EPS of -$0.09, which missed the consensus estimate of $0.43 by $0.52. With a trailing EPS of $4.12 and a P/E Ratio of 1.17,

Upcoming Q3
Earnings Date
Nov. 12After Market ClosesEstimated
Consensus EPS
(Aug. 10)
$0.43
Actual EPS
(Aug. 10)
-$0.09 Missed By -$0.52

Q2 2026 Earnings Resources

ORMP Upcoming Earnings

Oramed Pharmaceuticals' next earnings date is estimated for Thursday, November 12, 2026, based on past reporting schedules.

Get Oramed Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oramed Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ORMP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Oramed Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20261$0.43$0.43$0.43
Q3 20261$0.52$0.52$0.52
Q4 20261$0.46$0.46$0.46

Oramed Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2026
(Estimated)
--------
8/10/2026Q2 2026$0.43-$0.09 -$0.52$1.84--
3/27/2026Q4 2025-$0.08-$0.06+$0.02$0.24$0.50M-
8/14/2025Q2 2025-$0.04-$0.05 -$0.01$0.31--
5/15/2025Q1 2025-$0.03-$0.19 -$0.16-$0.19-$2.00M
3/27/2025Q4 2024-$0.03$0.01+$0.04$0.01--

Earnings data for NASDAQ:ORMP is sourced from Fiscal.ai, with the most recent quarter reported on 8/10/2026. New results are added as companies report their earnings.
From Our Partners